Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd.

Why is Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd. ?

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of -3.07% and Operating profit at -9.90% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 4.72% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of -3.07% and Operating profit at -9.90% over the last 5 years

The company has declared Negative results for the last 4 consecutive quarters

INTEREST(HY) At CNY 0.23 MM has Grown at 544.76%
OPERATING CASH FLOW(Y) Lowest at CNY 51.08 MM
DEBT-EQUITY RATIO (HY) Highest at -25.5 %

With ROE of 4.27%, it has a fair valuation with a 0.00 Price to Book Value

Over the past year, while the stock has generated a return of 10.22%, its profits have fallen by -10.9%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd. for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd.

13.91%

0.75

31.24%

China Shanghai Composite

16.01%

1.03

14.98%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-3.07%

EBIT Growth (5y)

-9.90%

EBIT to Interest (avg)

34.61

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.28

Sales to Capital Employed (avg)

0.26

Tax Ratio

13.74%

Dividend Payout Ratio

50.26%

Pledged Shares

Institutional Holding

ROCE (avg)

9.15%

ROE (avg)

4.72%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

-6.88

EV to EBITDA

-4.03

EV to Capital Employed

-0.38

EV to Sales

-1.00

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

4.27%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

INVENTORY TURNOVER RATIO(HY)

Highest at 2.87 times

RAW MATERIAL COST(Y)

Fallen by -8.37% (YoY

-17What is not working for the Company

INTEREST(HY)

At CNY 0.23 MM has Grown at 544.76%

OPERATING CASH FLOW(Y)

Lowest at CNY 51.08 MM

DEBT-EQUITY RATIO (HY)

Highest at -25.5 %

INTEREST COVERAGE RATIO(Q)

Lowest at 6,411.14

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.8 times

OPERATING PROFIT(Q)

Lowest at CNY 6.06 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 9.99 %

Here's what is working for Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd.

Inventory Turnover Ratio

Highest at 2.87 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -8.37% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd.

Interest

At CNY 0.23 MM has Grown at 544.76%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 6,411.14

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio

Highest at -25.5 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow

Lowest at CNY 51.08 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit

Lowest at CNY 6.06 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 9.99 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debtors Turnover Ratio

Lowest at 3.8 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio